Logo image of 1TMO.MI

THERMO FISHER SCIENTIFIC INC (1TMO.MI) Stock Fundamental Analysis

BIT:1TMO - Euronext Milan - US8835561023 - Common Stock - Currency: EUR

352.65  +2.9 (+0.83%)

Fundamental Rating

5

Overall 1TMO gets a fundamental rating of 5 out of 10. We evaluated 1TMO against 959 industry peers in the Life Sciences Tools & Services industry. 1TMO has an excellent profitability rating, but there are some minor concerns on its financial health. 1TMO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1TMO had positive earnings in the past year.
In the past year 1TMO had a positive cash flow from operations.
In the past 5 years 1TMO has always been profitable.
Each year in the past 5 years 1TMO had a positive operating cash flow.
1TMO.MI Yearly Net Income VS EBIT VS OCF VS FCF1TMO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

With an excellent Return On Assets value of 6.58%, 1TMO belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
1TMO has a Return On Equity of 13.19%. This is amongst the best in the industry. 1TMO outperforms 88.89% of its industry peers.
The Return On Invested Capital of 1TMO (6.85%) is better than 66.67% of its industry peers.
1TMO had an Average Return On Invested Capital over the past 3 years of 7.10%. This is below the industry average of 11.64%.
Industry RankSector Rank
ROA 6.58%
ROE 13.19%
ROIC 6.85%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)7.1%
ROIC(5y)8.12%
1TMO.MI Yearly ROA, ROE, ROIC1TMO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of 1TMO (15.19%) is better than 88.89% of its industry peers.
1TMO's Profit Margin has been stable in the last couple of years.
The Operating Margin of 1TMO (18.27%) is better than 72.22% of its industry peers.
1TMO's Operating Margin has improved in the last couple of years.
1TMO has a Gross Margin (41.34%) which is in line with its industry peers.
1TMO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.27%
PM (TTM) 15.19%
GM 41.34%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
1TMO.MI Yearly Profit, Operating, Gross Margins1TMO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1TMO is destroying value.
1TMO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1TMO has less shares outstanding
The debt/assets ratio for 1TMO has been reduced compared to a year ago.
1TMO.MI Yearly Shares Outstanding1TMO.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
1TMO.MI Yearly Total Debt VS Total Assets1TMO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

1TMO has an Altman-Z score of 3.43. This indicates that 1TMO is financially healthy and has little risk of bankruptcy at the moment.
1TMO has a better Altman-Z score (3.43) than 66.67% of its industry peers.
The Debt to FCF ratio of 1TMO is 5.08, which is a neutral value as it means it would take 1TMO, 5.08 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.08, 1TMO perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
A Debt/Equity ratio of 0.64 indicates that 1TMO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, 1TMO is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.08
Altman-Z 3.43
ROIC/WACC0.67
WACC10.18%
1TMO.MI Yearly LT Debt VS Equity VS FCF1TMO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

1TMO has a Current Ratio of 1.77. This is a normal value and indicates that 1TMO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1TMO (1.77) is better than 66.67% of its industry peers.
A Quick Ratio of 1.38 indicates that 1TMO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.38, 1TMO is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.38
1TMO.MI Yearly Current Assets VS Current Liabilites1TMO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.30% over the past year.
1TMO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
1TMO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.96%.
1TMO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%

3.2 Future

1TMO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.41% yearly.
The Revenue is expected to grow by 4.71% on average over the next years.
EPS Next Y3.08%
EPS Next 2Y6.81%
EPS Next 3Y8.35%
EPS Next 5Y11.41%
Revenue Next Year2.11%
Revenue Next 2Y4.09%
Revenue Next 3Y4.98%
Revenue Next 5Y4.71%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1TMO.MI Yearly Revenue VS Estimates1TMO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
1TMO.MI Yearly EPS VS Estimates1TMO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

1TMO is valuated rather expensively with a Price/Earnings ratio of 18.40.
83.33% of the companies in the same industry are more expensive than 1TMO, based on the Price/Earnings ratio.
1TMO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.52.
A Price/Forward Earnings ratio of 16.15 indicates a correct valuation of 1TMO.
Based on the Price/Forward Earnings ratio, 1TMO is valued a bit cheaper than 72.22% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1TMO to the average of the S&P500 Index (22.25), we can say 1TMO is valued slightly cheaper.
Industry RankSector Rank
PE 18.4
Fwd PE 16.15
1TMO.MI Price Earnings VS Forward Price Earnings1TMO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

1TMO's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1TMO.
Industry RankSector Rank
P/FCF 22.61
EV/EBITDA 16.5
1TMO.MI Per share data1TMO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1TMO does not grow enough to justify the current Price/Earnings ratio.
1TMO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.97
PEG (5Y)1.52
EPS Next 2Y6.81%
EPS Next 3Y8.35%

3

5. Dividend

5.1 Amount

1TMO has a yearly dividend return of 0.43%, which is pretty low.
1TMO's Dividend Yield is comparable with the industry average which is at 2.85.
Compared to an average S&P500 Dividend Yield of 2.38, 1TMO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

On average, the dividend of 1TMO grows each year by 15.37%, which is quite nice.
Dividend Growth(5Y)15.37%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

9.16% of the earnings are spent on dividend by 1TMO. This is a low number and sustainable payout ratio.
The dividend of 1TMO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP9.16%
EPS Next 2Y6.81%
EPS Next 3Y8.35%
1TMO.MI Yearly Income VS Free CF VS Dividend1TMO.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
1TMO.MI Dividend Payout.1TMO.MI Dividend Payout, showing the Payout Ratio.1TMO.MI Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

BIT:1TMO (6/3/2025, 7:00:00 PM)

352.65

+2.9 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-23 2025-04-23/bmo
Earnings (Next)07-22 2025-07-22/bmo
Inst Owners91.19%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap133.12B
Analysts81.08
Price Target511.86 (45.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend1.34
Dividend Growth(5Y)15.37%
DP9.16%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.81%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.69%
EPS beat(4)2
Avg EPS beat(4)1.26%
Min EPS beat(4)-0.34%
Max EPS beat(4)3.75%
EPS beat(8)4
Avg EPS beat(8)0.79%
EPS beat(12)7
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)5.33%
Revenue beat(2)2
Avg Revenue beat(2)0.16%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.53%
Revenue beat(16)11
Avg Revenue beat(16)3.62%
PT rev (1m)-17.05%
PT rev (3m)-17.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.6%
EPS NY rev (1m)-4.04%
EPS NY rev (3m)-4.25%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 18.4
Fwd PE 16.15
P/S 3.54
P/FCF 22.61
P/OCF 18.68
P/B 3.08
P/tB N/A
EV/EBITDA 16.5
EPS(TTM)19.17
EY5.44%
EPS(NY)21.83
Fwd EY6.19%
FCF(TTM)15.6
FCFY4.42%
OCF(TTM)18.88
OCFY5.35%
SpS99.48
BVpS114.54
TBVpS-28.82
PEG (NY)5.97
PEG (5Y)1.52
Profitability
Industry RankSector Rank
ROA 6.58%
ROE 13.19%
ROCE 9.13%
ROIC 6.85%
ROICexc 7.36%
ROICexgc 32.47%
OM 18.27%
PM (TTM) 15.19%
GM 41.34%
FCFM 15.68%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)7.1%
ROIC(5y)8.12%
ROICexc(3y)7.8%
ROICexc(5y)9.07%
ROICexgc(3y)38.8%
ROICexgc(5y)44.27%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score8
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 5.08
Debt/EBITDA 2.9
Cap/Depr 47.53%
Cap/Sales 3.3%
Interest Coverage 250
Cash Conversion 75.27%
Profit Quality 103.22%
Current Ratio 1.77
Quick Ratio 1.38
Altman-Z 3.43
F-Score8
WACC10.18%
ROIC/WACC0.67
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
EPS Next Y3.08%
EPS Next 2Y6.81%
EPS Next 3Y8.35%
EPS Next 5Y11.41%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%
Revenue Next Year2.11%
Revenue Next 2Y4.09%
Revenue Next 3Y4.98%
Revenue Next 5Y4.71%
EBIT growth 1Y6.86%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year12.01%
EBIT Next 3Y9.78%
EBIT Next 5Y10.83%
FCF growth 1Y19.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y5.98%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%